Oral GW766944 (Oral CCR3 Antagonist)
NCT01160224
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
GW766944
OTHER:
Placebo
Sponsor
GlaxoSmithKline